Novo Nordisk Inc. Receives Award from Major Physician College

Publish Date:

Monday, April 18, 2011 3:00 am EDT


SAN DIEGO —April 18, 2011— Novo Nordisk Inc. was presented the Corporate Philanthropy Award at the Platinum Level by the American College of Endocrinology (ACE) at its Convocation during the American Association of Clinical Endocrinologists (AACE) 20th Annual Meeting and Clinical Congress in San Diego, on Saturday, April 16, 2011.
The Corporate Philanthropy Award is presented to corporate sponsors who have made significant contributions to ACE at one of three thresholds: Silver, Gold or Platinum. The award was established in 2009. 
“On behalf of Novo Nordisk, it’s an honor to receive this award which highlights our commitment to changing diabetes by improving knowledge and education that benefits physicians and patients,” said Jerzy Gruhn, president, Novo Nordisk, Inc. “But we also wish to thank the endocrinologists who continually dedicate their lives to those coping with this serious disease. We look forward to continuing this important partnership in the future.”
Novo Nordisk is a health care company with an 87-year history of innovation and achievement in diabetes care. Novo Nordisk is Changing Diabetes® by helping to improve diabetes care through partnerships, research, products and services that make a significant difference to patients, the medical profession and society at large. Its portfolio of diabetes pharmaceuticals and delivery systems is the most comprehensive available and now includes the first human glucagon-like peptide-1 (GLP-1) analog for the treatment of diabetes. 
In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women.
About the American College of Endocrinology (ACE)
The American College of Endocrinology (ACE) is the educational and scientific arm of the American Association of Clinical Endocrinologists (AACE). The American College of Endocrinology is a scientific, educational and charitable medical organization dedicated to promoting the art and science of clinical endocrinology, diabetes, and metabolism for the improvement of patient care and public health.